DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,143,779 | -6.9% | 20,733 | -9.9% | 1.45% | -7.5% |
Q2 2023 | $5,525,280 | -6.0% | 23,022 | -1.3% | 1.57% | -10.9% |
Q1 2023 | $5,877,740 | -6.5% | 23,321 | -1.5% | 1.76% | -12.3% |
Q4 2022 | $6,283,752 | +1.3% | 23,676 | -1.5% | 2.01% | -15.6% |
Q3 2022 | $6,205,000 | +0.8% | 24,025 | -1.1% | 2.38% | +6.2% |
Q2 2022 | $6,157,000 | -14.5% | 24,287 | -1.1% | 2.24% | +0.3% |
Q1 2022 | $7,200,000 | -10.7% | 24,548 | +0.2% | 2.24% | -5.5% |
Q4 2021 | $8,064,000 | +7.4% | 24,510 | -0.7% | 2.36% | +0.6% |
Q3 2021 | $7,511,000 | +9.6% | 24,673 | -3.4% | 2.35% | +11.4% |
Q2 2021 | $6,854,000 | +17.5% | 25,542 | -1.4% | 2.11% | +8.5% |
Q1 2021 | $5,833,000 | -3.9% | 25,916 | -5.1% | 1.94% | -6.1% |
Q4 2020 | $6,069,000 | +2.1% | 27,321 | -1.0% | 2.07% | -12.7% |
Q3 2020 | $5,945,000 | +19.4% | 27,609 | -1.9% | 2.37% | +15.9% |
Q2 2020 | $4,977,000 | +30.6% | 28,146 | +2.3% | 2.05% | +5.5% |
Q1 2020 | $3,810,000 | -14.0% | 27,525 | -4.7% | 1.94% | +6.9% |
Q4 2019 | $4,431,000 | +9.0% | 28,871 | +2.6% | 1.82% | +0.8% |
Q3 2019 | $4,065,000 | +0.7% | 28,147 | -0.4% | 1.80% | -1.9% |
Q2 2019 | $4,038,000 | +4.1% | 28,253 | -3.9% | 1.84% | +1.7% |
Q1 2019 | $3,880,000 | +28.8% | 29,392 | +0.6% | 1.80% | +14.4% |
Q4 2018 | $3,012,000 | -5.0% | 29,206 | +0.1% | 1.58% | +7.2% |
Q3 2018 | $3,170,000 | +9.6% | 29,175 | -0.4% | 1.47% | +2.9% |
Q2 2018 | $2,892,000 | -0.2% | 29,303 | -1.0% | 1.43% | -0.7% |
Q1 2018 | $2,898,000 | +7.5% | 29,596 | +1.9% | 1.44% | +6.9% |
Q4 2017 | $2,695,000 | +8.7% | 29,035 | +0.5% | 1.35% | +4.6% |
Q3 2017 | $2,479,000 | +2.7% | 28,904 | +1.1% | 1.29% | -0.9% |
Q2 2017 | $2,414,000 | +0.8% | 28,602 | +2.1% | 1.30% | -7.8% |
Q1 2017 | $2,396,000 | +9.2% | 28,017 | -0.6% | 1.41% | +5.8% |
Q4 2016 | $2,195,000 | +0.6% | 28,194 | +1.3% | 1.33% | -3.7% |
Q3 2016 | $2,181,000 | -19.7% | 27,827 | +3.5% | 1.38% | -22.8% |
Q2 2016 | $2,716,000 | +9.7% | 26,895 | +3.1% | 1.79% | +6.4% |
Q1 2016 | $2,475,000 | -4.8% | 26,088 | -6.8% | 1.68% | -13.6% |
Q4 2015 | $2,600,000 | +8.4% | 27,991 | -0.6% | 1.95% | +0.9% |
Q3 2015 | $2,399,000 | -0.5% | 28,155 | -0.0% | 1.93% | +6.2% |
Q2 2015 | $2,411,000 | +2.2% | 28,164 | +1.3% | 1.82% | +0.1% |
Q1 2015 | $2,360,000 | -2.1% | 27,793 | -1.2% | 1.82% | -5.5% |
Q4 2014 | $2,411,000 | +13.0% | 28,134 | +0.2% | 1.92% | +7.3% |
Q3 2014 | $2,133,000 | -1.9% | 28,080 | +1.7% | 1.79% | -11.7% |
Q2 2014 | $2,174,000 | +5.0% | 27,620 | +0.0% | 2.03% | +1.6% |
Q1 2014 | $2,071,000 | -5.4% | 27,618 | -2.6% | 2.00% | -7.2% |
Q4 2013 | $2,189,000 | – | 28,351 | – | 2.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |